2012 AACU STATE SOCIETY NETWORK ADVOCACY CONFERENCE
September 22-23, 2012
The American Association of Clinical Urologists held its 5th Annual State Society Network Advocacy Conference in late September 2012. During the conference, New Jersey Assemblyman Herb Conaway, Jr., MD accepted the organization’s Distinguished Leadership Award, having been nominated by urologists in New Jersey for his work promoting the interests of patients and physicians in the legislature. Of these urologists, New Jersey Patient Care and Access Coalition President David Taylor, MD sponsored this nomination. Dr. Taylor highlighted Dr. Conaway’s commitment to public service as well as leadership on issues very important to the urologic community.
Dr. Conaway has served in the New Jersey General Assembly since 1998, as the only member with both a medical and law degree. He specializes in internal medicines and practices in Willingboro where he supports and focusses on prostate-specific antigen-based screening for prostate cancer and access to patient-centered integrated care.
June 18-21, 2012 – New Jersey
The New Jersey Patient Care and Access Coalition commemorated “Prostate Cancer Awareness Month” in New Jersey with a special educational display in the State House in Trenton the week of June 18th through 21st.
Participating in the event were:
Dr. David Taylor, President and Chairman of NJPCAC
NJPCAC Board Member Alan Plotkin
NJPCAC Board Member Dr. Eric Seaman
NJPCAC Board Member Mary Beth Guilbert
Dr. Bill Niedrach from Delaware Valley Urology
Kelly Snyder from The Stone Center
NJPCAC Lobbyist Donald Sico
The group was able to have conversations with scores of legislators and staffers during the week and help educate them regarding prostate cancer treatment and symptoms as well as the dangerous United States Preventative Services Task Force recommendations on PSA screening. In addition, the Great Prostate Cancer Challenge race in September was promoted.
NEW JERSEY LEADS THE NATION IN OPPOSING USPSTF PSA TESTING RECOMMENDATION
January 17, 2012 – New Jersey
TRENTON, NJ – New Jersey Governor Chris Christie today signed legislation promoted by the New Jersey Patient Care and Access Coalition (NJPCAC) opposing an October 2011 U.S. Preventive Services Task Force (USPSTF) draft recommendation that healthy men should no longer receive prostate-specific antigen (PSA) blood tests as part of routine cancer screening.
NJPCAC HOSTS LEGISLATOR OPEN HOUSE IN HONOR OF PROSTATE CANCER AWARENESS MONTH
October 1, 2010 – New Jersey
The New Jersey Patient Care and Access Coalition (NJPCAC), a coalition of over 160 top urologists and healthcare professionals, will host an open house event on September 30 from 1-4 pm in Room 109 (State House) in honor of September being recognized as Prostate Cancer Awareness Month.
The New Jersey Patient Care and Access Coalition, comprised of more than 160 urologists from across the State, announced today a partnership with ZERO – The Project to End Prostate Cancer to host a Great Prostate Cancer Challenge 5k Race in 2011 that will raise money to promote prostate cancer awareness, early detection and research.
NJPCAC TAPPED TO ASSIST LEGISLATIVE LEADERSHIP IN DRAFTING NEW JERSEY’S LAWS ON OUT OF NETWORK PROVIDERS
April 8, 2010 – New Jersey
The New Jersey Patient Care and Access Coalition (NJPCAC), comprised of more than 160 urologists from across the State, has been asked by Gary Schaer, Chair of the Assembly Financial Institutions and Insurance Committee, to participate in a small panel of stakeholders to craft legislation directed at addressing the challenges surrounding those health care professionals and facilities that opt out of insurance company networks.
COALITION FORMED TO PRESERVE ACCESS TO HIGHEST QUALITY UROLOGICAL CARE FOR NEW JERSEY PATIENTS
September 25, 2008 – New Jersey
A statewide collection of multi-specialty physician group practices have formed a coalition aimed at promoting and protecting the highest quality urologic care for New Jersey patients. The New Jersey Patient Care and Access Coalition (NJPCAC) will seek to educate and partner with policy makers, regulators, insurers and other key stakeholders, including patients and other physician organizations, to ensure that New Jersey citizens continue to have access to the highest quality urologic care, including an integrated and comprehensive approach to the diagnosis and treatment of prostate cancer.